These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


201 related items for PubMed ID: 6433613

  • 1. Inhibition of folliculogenesis in the monkey following early follicular phase administration of an LRH agonist.
    Wilks JW.
    Acta Endocrinol (Copenh); 1984 Aug; 106(4):538-43. PubMed ID: 6433613
    [Abstract] [Full Text] [Related]

  • 2. Early follicular phase luteinizing hormone-releasing hormone agonist administration - effects on follicular maturation and corpus luteum function in women.
    Skarin G, Nillius SJ, Wide L.
    Contraception; 1982 Jan; 25(1):31-9. PubMed ID: 6800690
    [Abstract] [Full Text] [Related]

  • 3. Follicular fluid treatment during the follicular versus luteal phase of the menstrual cycle: effects on corpus luteum function.
    Stouffer RL, Hodgen GD, Ottobre AC, Christian CD.
    J Clin Endocrinol Metab; 1984 Jun; 58(6):1027-33. PubMed ID: 6427256
    [Abstract] [Full Text] [Related]

  • 4. Administration of luteinizing hormone-releasing hormone analogs delays ovulation without affecting the luteal function in rhesus monkeys.
    Borghi MR, Niesvisky R, Balmaceda JP, Coy DH, Schally AV, Asch RH.
    Fertil Steril; 1983 Nov; 40(5):678-82. PubMed ID: 6414849
    [Abstract] [Full Text] [Related]

  • 5. Low-dose follicular-phase cocaine administration disrupts menstrual and ovarian cyclicity in rhesus monkeys.
    Potter DA, Luther MF, Eddy CA, Siler-Khodr TM, King TS, Schenken RS.
    J Soc Gynecol Investig; 1999 Nov; 6(2):88-94. PubMed ID: 10205779
    [Abstract] [Full Text] [Related]

  • 6. The sequence of pituitary responses to synthetic luteinizing hormone releasing hormone (LH-RH) throughout the normal menstrual cycle.
    Grimes EM, Thompson IE, Taymor ML.
    Acta Endocrinol (Copenh); 1975 Aug; 79(4):625-34. PubMed ID: 1098349
    [Abstract] [Full Text] [Related]

  • 7. Initiation of high dose gonadotrophin-releasing hormone antagonist treatment during the late follicular phase in the macaque abolishes luteal function irrespective of effects upon the luteinizing hormone surge.
    Fraser HM, Lunn SF, Morris KD, Deghenghi R.
    Hum Reprod; 1997 Mar; 12(3):430-5. PubMed ID: 9130734
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of ovulation in women by chronic treatment with a stimulatory LRH analogue--a new approach to birth control?
    Nillius SJ, Bergquist C, Wide L.
    Contraception; 1978 Jun; 17(6):537-45. PubMed ID: 352612
    [Abstract] [Full Text] [Related]

  • 9. Suppression of luteal function by a luteinizing hormone-releasing hormone antagonist during the early luteal phase in the stumptailed macaque monkey and the effects of subsequent administration of human chorionic gonadotropin.
    Fraser HM, Nestor JJ, Vickery BH.
    Endocrinology; 1987 Aug; 121(2):612-8. PubMed ID: 3109885
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Inhibition of ovulation during discontinuous intranasal luteinizing hormone-releasing hormone agonist dosing in combination with gestagen-induced bleeding.
    Lemay A, Faure N, Labrie F, Fazekas AT.
    Fertil Steril; 1985 Jun; 43(6):868-77. PubMed ID: 3158551
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of prolonged luteinizing hormone-releasing hormone therapy on follicular maturation, ovulation and corpus luteum function in amenorrhoeic women with anorexia nervosa.
    Nillius SJ, Wide L.
    Ups J Med Sci; 1979 Jun; 84(1):21-35. PubMed ID: 375526
    [Abstract] [Full Text] [Related]

  • 15. Onapristone (ZK 98.299): a potential antiprogestin for endometrial contraception.
    Katkam RR, Gopalkrishnan K, Chwalisz K, Schillinger E, Puri CP.
    Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):779-87. PubMed ID: 7573244
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Luteal phase defects in the rhesus monkey: the significance of serum FSH:LH ratios.
    Wilks JW, Hodgen GD, Ross GT.
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1261-7. PubMed ID: 826543
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Inhibition of preovulatory gonadotropin secretion in the rhesus monkey by [(<Glu-Pro)1,D-Phe2,D-Trp3,6]-LHRH.
    Wilks JW, Folkers K, Bowers CY, Humphries J, Schircks B, Friebel K.
    Contraception; 1980 Sep; 22(3):313-23. PubMed ID: 6777114
    [Abstract] [Full Text] [Related]

  • 20. Ablation of folliculogenesis in women by a single dose of gonadotropin-releasing hormone agonist: significance of time in cycle.
    Monroe SE, Henzl MR, Martin MC, Schriock E, Lewis V, Nerenberg C, Jaffe RB.
    Fertil Steril; 1985 Mar; 43(3):361-8. PubMed ID: 3156770
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.